DNA Conformation Mediates Aflatoxin B1-DNA Binding and the Formation of Guanine N7 Adducts by Aflatoxin B1 8,9-exo-epoxide
Overview
Authors
Affiliations
The binding of aflatoxin B1 to DNA and DNA adduction by aflatoxin B1 exo-8,9-epoxide were studied as a function of DNA conformation. Equilibrium binding of aflatoxin B1 to A-, B-, and Z-form helices was monitored by measurement of NMR linewidth for the methoxy protons of aflatoxin B1. The data revealed that as compared to B-form DNA, the association of aflatoxin with the A-form helix is significantly reduced. No binding to Z-DNA was observed. The yields obtained following reaction of the respective monomers with aflatoxin B1 exo-8,9-epoxide revealed that only dG forms an adduct. The reactivity of aflatoxin B1 exo-8,9-epoxide with single-strand DNA was determined via constant-temperature experiments in which the yield of adduct was measured for a family of oligonucleotides of increasing thermal stability. The results demonstrate that duplex structure favors adduct formation. Adduct yields were compared for A-, B-, and Z-form helices. About 12 times less adduct is produced from the A-form helix as compared to B-form, while no adduct is produced from a Z-form duplex. The results support the conclusion that reaction of aflatoxin B1 exo-8,9-epoxide with DNA proceeds via an intercalated transition-state complex only with the B-form double helix.
Kipkoech G, Jepkorir M, Kamau S, Wanyoko A, Kibunja S, Amozi Jeremiah R Open Res Afr. 2025; 6:22.
PMID: 40060373 PMC: 11885904. DOI: 10.12688/openresafrica.14406.2.
Szilveszter R, Muntean M, Florea A Biomolecules. 2024; 14(6).
PMID: 38927059 PMC: 11201617. DOI: 10.3390/biom14060656.
Development and Limitations of Exposure Biomarkers to Dietary Contaminants Mycotoxins.
Turner P, Snyder J Toxins (Basel). 2021; 13(5).
PMID: 33924868 PMC: 8147022. DOI: 10.3390/toxins13050314.
Risk Factors and Biomarkers for Chronic Hepatitis B Associated Hepatocellular Carcinoma.
Pandyarajan V, Govalan R, Yang J Int J Mol Sci. 2021; 22(2).
PMID: 33418899 PMC: 7825109. DOI: 10.3390/ijms22020479.
Jaksic D, Segvic Klaric M, Crnolatac I, Sijakovic Vujicic N, Smrecki V, Gorecki M Mar Drugs. 2019; 17(11).
PMID: 31698712 PMC: 6891739. DOI: 10.3390/md17110629.